Regulators from the Food and Drug Administration on Wednesday will consider a potentially safer alternative to cigarettes. Philip Morris International, the maker of Marlboro and other top brands, ...

As vapes get an even shadier rep — with more than 1,000 cases of severe lung disease apparently linked to the products, at the Center for Disease Control’s latest count — Altria has introduced Iqos, a ...

Q3 2025 Earnings Call Transcript October 21, 2025 Philip Morris International Inc. beats earnings expectations. Reported EPS ...

Philip Morris International (($PM)) has held its Q3 earnings call. Read on for the main highlights of the call. Philip Morris International’s ...

TOKYO/NEUCHATEL, Switzerland – The U.S. Food and Drug Administration is weighing whether to approve a potentially path-breaking smoking device by Philip Morris International Inc. With a decision ...

Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...

Shares of the global tobacco company sank as growth in its next-generation product disappointed. According to data from S&P Global Market Intelligence, the stock finished the year down 37%. Those ...

Philip Morris (NYSE: PM) recently reported its Q1 results, with revenues and earnings above the street estimates. The company reported revenue of $8.8 billion and adjusted earnings of $1.50 per share, ...

The U.S. trade body said Philip Morris International and Altria had 60 days to remove IQOS from store shelves. If the Juul e-cig doesn't get approved by the FDA, Altria may be without any e-cigs on ...

WASHINGTON — The Food and Drug Administration said Tuesday that it would permit the sale of IQOS, a “heat not burn” tobacco device made by Philip Morris International, in the United States. While the ...